[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
July 1988

Flow Cytometric Measurements of Nuclear DNA and Ploidy Analysis in Hürthle Cell Neoplasms of the Thyroid

Author Affiliations

From the Departments of Surgery (Drs McLeod, Thompson, and Harness) and Pathology (Drs Hudson, Gaglio, and Lloyd), University of Michigan Medical Center, Ann Arbor; the Department of Pathology, Maine Medical Center, Portland (Dr Nishiyama); and the Department of Surgery, University of Hong Kong, Queen Mary Hospital (Dr Cheung).

Arch Surg. 1988;123(7):849-854. doi:10.1001/archsurg.1988.01400310063010

• Nuclear DNA content and nuclear DNA ploidy were measured In 36 Hürthle cell neoplasms (HCNs) to better define their potential roles in predicting the clinical behavior of these lesions. An EPICS V flow cytometer (Coulter Electronics, Hialeah, Fla) was used. Measurements were taken from paraffin-embedded tissue. Isolated nuclei were stained with propidium iodide. The study was conducted in a blinded fashion. Observed NDC and PDY patterns were classified as diploid, aneuploid, or suspicious. Twenty-nine lesions (81%) were diploid and seven (19%) were aneuploid. Twelve (33%) HCNs were malignant, 23 (64%) were benign, and one (3%) was Indeterminate. Eight (67%) of 12 malignant HCNs were diploid and four (33%) of 12 were aneuploid. In comparison, 20 (87%) of 23 benign lesions were diploid and three (13%) of 23 were aneuploid. The indeterminate neoplasm was diploid. There were three deaths in this group of patients; all three had aneuploid neoplasms, and all had locally recurrent disease with distant metastases. There was a significant cross correlation between histologic features and DNA content with regard to outcome. These preliminary data suggest that NDC and PDY are not helpful in distinguishing histologically benign from malignant HCNs; however, they may be useful in determining prognosis.

(Arch Surg 1988;123:849-854)

Watson RG, Brennan MD, Goellner JR, et al:  Invasive Hürthle cell carcinoma of the thyroid: Natural history and management . Mayo Clin Proc 1984;59:851-855.Article
Tollefsen HR, Shah JP, Huvos AG:  Hürthle cell carcinoma of the thyroid . Am J Surg 1975;130:390-394.Article
Chesky VE, Dreese WC, Hellwig CA:  Hürthle cell tumors of the thyroid gland: A report of 25 cases . J Clin Endocrinol Metab 1951;11:1535-1548.Article
Gardner LW:  Hürthle cell tumors of the thyroid . Arch Pathol 1955;59:372-381.
Bondeson L, Bondeson AG, Ljungberg O, et al:  Oxyphil tumors of the thyroid . Ann Surg 1981;194:677-680.Article
Thompson NW, Dunn EL, Batsakis JG, et al:  Hürthle cell lesions of the thyroid gland . Surg Gynecol Obstet 1974;139:555-560.
Gundry SR, Burney RE, Thompson NW:  Total thyroidectomy for Hürthle cell neoplasm of the thyroid . Arch Surg 1983;118:529-532.Article
Miller RH, Estrada R, Sneed WF, et al:  Hürthle cell tumors of the thyroid gland . Laryngoscope 1983;93:884-888.
Gosain AK, Clark OH:  Hürthle cell neoplasms . Arch Surg 1984; 119:515-519.Article
Caplan RH, Abellera M, Kisken WA:  Hürthle cell tumors of the thyroid gland: A clinicopathologic review and long-term follow-up . JAMA 1984;251:3114-3117.Article
Bondeson L, Azavedo E, Bondeson AG, et al:  Nuclear DNA content and behavior of oxyphil thyroid tumors . Cancer 1986;58:672-675.Article
Backdahl M, Auer G, Forsslund G:  Prognostic value of nuclear DNA content in follicular thyroid tumours . Acta Chir Scand 1986;152:1-7.
Backdahl M, Carstensen J, Auer G, et al:  Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular, and medullary thyroid tumors . World J Surg 1986;10:974-980.Article
Cohn K, Backdahl M, Forsslund G, et al:  Prognostic value of nuclear DNA content in papillary thyroid carcinoma . World J Surg 1984;8:474-480.Article
Backdahl M, Cohn K, Auer G, et al:  Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma . Cancer Res 1985;45:2890-2894.
Bengtsson A, Malmaeus J, Grimelius L, et al:  Measurement of nuclear DNA content in thyroid diagnosis . World J Surg 1984;8:481-486.Article
Greenbaum E, Koss LG, Elequin F, et al:  The diagnostic value of flow cytometric DNA measurements in follicular tumors of the thyroid gland . Cancer 1985;56:2011-2018.Article
Kraemer BB, Srigley JR, Batsakis JG, et al:  DNA flow cytometry of thyroid neoplasms . Arch Otolaryngol Head Neck Surg 1985;111:34-38.Article
Lukacs GL, Balazs G, Zs-Nagy I:  Cytofluorimetric measurements on the DNA contents of tumor cells in human thyroid gland . J Cancer Res Clin Oncol 1979;95:265-271.Article
Lukacs GL, Miko TL, Fabian E, et al:  The validity of some morphologic methods in the diagnosis of thyroid malignancy . Acta Chir Scand 1983;149:759-766.
Hedley DW, Friedlander ML, Taylor IW, et al:  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance . Cytometry 1985;6:327-333.Article
Hedley DW, Friedlander ML, Taylor IW, et al:  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry . J Histochem Cytochem 1983;31:1333-1335.Article
Clevenger CV, Bauer KD, Epstein AL:  A method for simultaneous nuclear immunofluorescence and DNA content quantitation using monoclonal antibodies and flow cytometry . Cytometry 1985;6:208-214.Article
Vindelov LL:  Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions . Virchows Arch B 1977;24:227-242.
Traganos F:  Flow cytometry: Principles and applications. II . Cancer Invest 1984;2:239-258.Article
Pollack A, Moulis H, Block NL, et al:  Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein . Cytometry 1984;5:473-481.Article
Bibbo M, Bartels PH, Dytch HE, et al:  Ploidy measurements by high-resolution cytometry . Anal Quant Cytol Histol 1985;7:82-88.
Joensuu H, Klemi P, Eerola E:  DNA aneuploidy in follicular adenomas of the thyroid gland . Am J Pathol 1986;124:373-376.
Haemmerli G, Strauli P, Schluter G:  Deoxyribonucleic acid measurements on nodular lesions of the human thyroid . Lab Invest 1968;18:675-680.
Johannessen JV, Sobrinho-Simoes M, Tangen KO, et al:  A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma . Lab Invest 1981;45:336-341.